Citation Impact
19 standout
Citing Papers
Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management
2023 Standout
Macrophages in immunoregulation and therapeutics
2023 Standout
Works of Sung-Nam Lim being referenced
Phase II trial of pexa-vec (pexastimogene devacirepvec; JX-594), an oncolytic and immunotherapeutic vaccinia virus, in patients with metastatic, refractory renal cell carcinoma (RCC).
2018
Therapeutic decision-making in elderly patients with acute myeloid leukemia: conventional intensive chemotherapy versus hypomethylating agent therapy
2017
Author Peers
| Author | Oncology | PFM | Hematology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|
| Sung-Nam Lim | 78 | 76 | 97 | 34 | 252 | |
| A.E. Graafhuis | 10 | 470 | ||||
| Koichiro Minauchi | 67 | 86 | 67 | 17 | 260 | |
| Markus A. Ebert | 46 | 1.2k | ||||
| Shabihul Fatma Abidi | 1 | 13 | 481 | |||
| Dušana Majera | 55 | 29 | 7 | 12 | 299 |
All Works
Loading papers...